An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-MT-8554 After a Single Oral Dose to Healthy Male Subjects

Trial Profile

An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-MT-8554 After a Single Oral Dose to Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Feb 2018

At a glance

  • Drugs MT 8554 (Primary)
  • Indications Diabetic neuropathies; Neurological disorders; Vasomotor symptoms
  • Focus Pharmacokinetics
  • Acronyms MT-8554 MB
  • Sponsors Mitsubishi Pharma America
  • Most Recent Events

    • 13 Feb 2018 Status changed from recruiting to completed.
    • 09 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 29 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top